Stock screener

PLSE

Conviction 100HealthcareScan · Thu, Sep 24, 2026

Pulse Biosciences, Inc. (PLSE) closed at $51.82 (-0.31%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 99, -6.1% from its 52-week high, +287.0% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

PLSE$51.82-0.31%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 763.22K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
PULSE BIOSCIENCES, INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.pulsebiosciences.com ↗
Price51.82
Change-0.31%
Gap+0.54%
Rel volume2.23×
Avg volume734.48K
Avg $ vol38.37M
SMA 2052.09
SMA 5044.42
SMA 20026.63
Price vs 50+16.65%
Price vs 200+94.58%
MA stackbullish
50/200 cross—
Supertrendup · 45.45
RSI (14)55
MACD hist-0.68
MACD cross—
Stoch %K / %D37 / 40
ADX (14)42
+DI / −DI22 / 13
RSI divergenceBearish
MACD divergenceBearish
ATR %7.29%
ADR %7.72%
52w high55.20
52w low12.66
From 52w high-6.12%
Above 52w low+309.32%
New 52w highNo
SqueezeOn · 2d
Bollinger width16.32%
%B0.47
Donchian pos40.45%
Donchian high58.90
Donchian low47.01
AVWAP (52w high)52.97
vs AVWAP high-2.16%
AVWAP (52w low)30.36
vs AVWAP low+70.67%
OBV trendUp
Chaikin MF (20)-0.15
Today vs 20d2.23×
Avg vol (14d)763.22K
Avg vol (20d)734.48K
Avg $ vol (20d)38.37M
Market cap3.7B
RS Rating99 / 99
RS 3m (vs SPY)+83.91%
RS 6m (vs SPY)+118.51%
RS line new highNo
Trend template8/8
Technical rank92.4
1 week+2.39%
1 month+5.76%
3 months+88.40%
6 months+135.33%
1 year+192.77%
YTD+287.01%
P/E-50.78
P/B37.15
P/S—
P/FCF-67.89
EPS-1.08
Div yield—
ROE-73.15%
ROA-62.98%
Debt/Eq—
Current9.63
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-35.82%
Price target54.00
Target upside4.21%
Analyst ratingBuy
Institutional16.36%
Ent. value3.59B
Revenue434K
Net income-24.66M
Gross profit—
Free cash flow-54.44M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out69.21M
Employees116
ListedWed, May 18, 2016
Free float18.17M
Float %26.6%
Short interest3.12M
Days to cover7.9d
Short volume49.4%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.36 vs −$0.31
Last surprise-16.1% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance57.76
Support44.52
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 31
    1 scan
  2. Breaking out now
    Sep 1
    1 scan

Congress activity

Disclosed STOCK Act trades in PLSE

All disclosures →
No recent disclosed trades by Congress in PLSE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLSE · open-market 6 buys

InsiderSideShares
Teplitsky Liane Rae
Chief Operating Officer · Common Stock · 2026-09-01
Buy1K
Teplitsky Liane Rae
Chief Operating Officer · Common Stock · 2026-08-31
Buy1.02K
Teplitsky Liane Rae
Chief Operating Officer · Common Stock · 2026-08-28
Buy1.03K
Teplitsky Liane Rae
Chief Operating Officer · Common Stock · 2026-08-26
Buy1.04K
Teplitsky Liane Rae
Chief Operating Officer · Stock Option (right to buy) · 2026-08-08
Grant700K
Teplitsky Liane Rae
Chief Operating Officer · Restricted Stock Units · 2026-08-08
Grant200K
Skinner Jon
Chief Financial Officer · Stock Option (right to buy) · 2025-02-03
Grant300K
DUGGAN ROBERT W
Director · Common Stock · 2026-05-11
Other—
DUGGAN ROBERT W
Director · Common Stock · 2026-05-11
Buy660.23K
LAVIOLETTE PAUL A
Chief Executive Officer · Common Stock · 2026-05-11
Buy15K

SEC filings

EDGAR filings in PLSE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.